Pune, Maharashtra, Okthoba 22 2020 (Wiredrelease) Ucwaningo Lwezithombe -:Ukwenyuka okungaguquguquki kwenani lamacala e-COVID-19 kubangele isidingo esinamandla sezixazululo zokutholwa kwegciwane. Izinsiza zokuhlonza i-COVID-19 zisetshenziselwa ukuhlaziya nokuthola ukuba khona kwegciwane le-SARS-CoV-2 kumuntu okungenzeka ukuthi unaleli gciwane.
Esifundeni sase-Asia Pacific lapho u-60% yenani labantu emhlabeni lihlala ezindaweni eziminyene, ubungozi be-COVID-19 bukhuphuka kancane naphezu kwemizamo yokuphatha. Ukwanda kokwanda kwe-coronavirus kube nomthelela emazweni amaningi ase-Asia Pacific ukuthi athathe izinyathelo ezinqala futhi akhuphule izinga lokuhlola nokuhlola.
Isicelo sesampula salo mbiko @ https://www.graphicalresearch.com/request/1364/sample
Ukuba khona kwemithetho kahulumeni evumayo kanye nokukhuphuka kokuqwashisa ngokuhlolwa kwe-coronavirus kukhuthaze izinkampani zezokunakekelwa kwempilo ukuthi zikhulise amandla okukhiqiza amakhithi okuhlola i-COVID-19. Kubikwa ukuthi, usayizi wemakethe wokuthola izinto e-Asia Pacific COVID-19 kulindeleke ukuthi udlule u-US$1.8 billion ngo-2026 mayelana nomholo waminyaka yonke. Okubalulwe ngezansi ezinye zezinto eziqhuba umbono wemakethe.
Imizamo kahulumeni yokulwa ne-COVID-19
Ngokuvumelana ne-Indian Council of Medical Research (ICMR), izinkampani zemishini yezokwelapha zase-India zingakhiqiza futhi zinikeze izinsiza zokuxilonga ezindaweni zokucwaninga zikahulumeni nezizimele ngemva kokwamukela ukwamukelwa yi-National Institute of Virology (NIV). Amafemu akumele alinde ukugunyazwa yi-CE yaseYurophu kanye ne-US FDA ngaphambi kokusabalalisa. Imizamo efanayo kulo lonke elase-Asia Pacific yokunqanda imingcele yokulawula kanye nokulwa nokusabalala kwegciwane izodala amathuba okuthuthukiswa nokudayiswa kwezinsiza zokuhlola.
Ukwanda kwesidingo samakhithi okuhlola e-RT-PCR
Imboni yekhithi yokuhlola i-COVID-19, ngokwemikhiqizo, ihlukaniswe yaba yimichilo yokuhlola i-immunoassay kanye namakhithi okuhlola e-RT-PCR. Indlela yokuhlola i-RT-PCR isabela kakhulu futhi icacile ngokwemvelo esiza ekutholeni ubukhona begciwane le-SARS-COV-2 kusampula yesiguli. Ngakolunye uhlangothi, indlela esekelwe ku-immunoassay ehlinzeka ngemiphumela esheshayo idinga nokuhlolwa kokuqinisekisa okuthunyelwe kusetshenziswa indlela ye-RT-PCR. Kubikwa ukuthi isabelo semakethe se-APAC RT-PCR assay kits kulindeleke ukuthi sikhuphuke cishe ku-20% CAGR eminyakeni ezayo.
Ukucaciswa kwe-nasopharyngeal swabs
Imboni yamakhithi okuthola i-COVID-19 ihlukaniswe yaba i-nasopharyngeal swab, i-nasal swab, i-oropharyngeal swab, nezinye izinhlobo zesampula. Ngenxa yokucaciswa okuphezulu kanye nesivuno esihle, ingxenye ye-nasopharyngeal swab inesabelo esikhulu semakethe esingaba ngu-45%, uma kuqhathaniswa nazo zonke ezinye izinhlobo zesampula. Ngaphandle kokuba nesabelo esiphawulekayo, izinkinga ngokusebenzisa i-nasal swab zifaka phakathi ukucaciswa okuphansi kanye nesivuno.
Okuncamelayo ukuhlola ezikhungweni zokuxilonga
Abasebenzisi bokuqala bezinsiza zokuhlonza i-COVID-19 e-Asia Pacific yizibhedlela nezikhungo zokuxilonga. Isidingo se-Kt kuzo zonke izikhungo zokuxilonga sasilinganiselwa cishe ezigidini ezingu-US$200 ngo-2020. Lokhu kungenxa yokuba nokwenzeka kokuhlolwa kulezi zikhungo. Ukutholakala kochwepheshe abanamakhono kanye nemishini ethuthukisiwe ezikhungweni zokuxilonga kwenza ukuhlola inani elikhulu lamasampula.
Yize inenani elimangalisayo lokululama elicishe libe ngama-80% kulesi sifo, i-India ibona isibalo esikhulu sabantu abashona ngenxa yokuntuleka kwengqalasizinda yokunakekelwa kwempilo eseqophelweni eliphezulu. Cishe ngezivivinyo ezibalelwa esigidini esisodwa ngosuku, kanye nokwesekwa kukahulumeni kwabaqalayo ababandakanyeka ekuhlolweni kwe-coronavirus yenoveli esebenzayo futhi emisha kuzothuthukisa ukufinyelela kumathuluzi ezweni. Usayizi wemakethe wamakhithi e-India COVID-1 ulinganiselwa ukuthi uzokhuphuka ku-CAGR ka-19% ngo-28. Imizamo emikhulu yokuqinisa amandla okulwa nobhubhane lwe-coronavirus, i-China, i-India, iNingizimu Korea namanye yandisa ukugxila kwabo ekukhiqizeni izinsiza zokuhlola.
Izinkampani ezihamba phambili ezihlinzeka ngezinsiza zokuhlonza i-COVID-19 esifundeni zifaka i-Shenzhen Bioeasy Biotechnology, Co-Diagnostics, Cepheid, BioFire Diagnostics, Guangzhou Wondfo Biotech, F. Hoffmann-La Roche, Qiagen, Mylab Discovery Solutions, SD Biosensor, Thermo Fisher Scientific, Seegene , Abbott, kanye ne-BGI.
Dlulisa amehlo embonini ebalulekile yomkhakha kanye ne-TOC @ https://www.graphicalresearch.com/table-of-content/1364/asia-pacific-covid-19-detection-kits-market
Mayelana Nocwaningo Lokuqhafaza:
I-Graphical Research yinkampani yocwaningo lwebhizinisi enikeza ukuqonda kwemboni, isibikezelo semakethe kanye nokufakwa kwamasu ngemibiko yocwaningo lwembumbulu kanye nezinsizakalo zokweluleka. Sishicilela imibiko yocwaningo ehlosiwe ngenhloso yokubhekana nezidingo ezahlukahlukene zamakhasimende, kusukela ekungeneni kwezimakethe namasu okungena kuya ekuphathweni kwephothifoliyo kanye nasekwenzeni amasu. Siyaqonda ukuthi izidingo zebhizinisi zehlukile: imibiko yethu yokuhlangana yenzelwe ukuqinisekisa ukubaluleka kwabahlanganyeli bemboni kulo lonke uchungechunge lwamavelu. Siphinde futhi sinikeze imibiko yangokwezifiso ehambelana nezidingo eziqondile zekhasimende, ngoxhaso lwabahlaziyi abazinikele kulo lonke uhlelo lokuphila lokuthenga.
Xhumana nathi:
UParikhit B.
Ukuthengiswa kwebhizinisi,
Ucwaningo Lokuqhafaza
Email: [i-imeyili ivikelwe]
Web: https://www.graphicalresearch.com
Lokhu okuqukethwe kushicilelwe yinkampani ye-Graphical Research. UMnyango Wezindaba WiredRelease awuzange ubambe iqhaza ekwenziweni kwalokhu okuqukethwe. Ngemibuzo yesevisi yokukhishwa kwabezindaba, sicela usifinyelele ku- [i-imeyili ivikelwe].
